Recombinant Anti-Integrin beta 4 antibody [EPR8559] (ab133682)
![Western blot - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)](https://www.abcam.com/ps/products/133/ab133682/Images/ab133682-147670-anti-integrin-beta-4-antibody-epr8559-western-blot.jpg "Western blot - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)")
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR8559] to Integrin beta 4
- Suitable for: WB, ICC/IF
- Reacts with: Human
Overview
-
Product name
Anti-Integrin beta 4 antibody [EPR8559]
See all Integrin beta 4 primary antibodies -
Description
Rabbit monoclonal [EPR8559] to Integrin beta 4 -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species ICC/IF HumanWB Human
-
Immunogen
Synthetic peptide within Human Integrin beta 4 aa 1750-1850 (C terminal). The exact sequence is proprietary.
-
Positive control
- BxPC-3 and SW480 cell lysates; BxPC-3 cells
-
General notes
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C. -
Dissociation constant (KD)
KD = 9.70 x 10 -11 M Learn more about KD -
Storage buffer
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading... -
Purity
Tissue culture supernatant -
Clonality
Monoclonal -
Clone number
EPR8559 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab133682 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Tested applications are guaranteed to work and covered by our Abpromise guarantee.
Predicted to work for this combination of applications and species but not guaranteed.
Does not work for this combination of applications and species.
| Application | Species |
|---|---|
| ICC/IF |
Human
|
| WB |
Human
|
| Application | Abreviews | Notes |
|---|---|---|
| WB |
1/1000 - 1/10000. Predicted molecular weight: 202 kDa.
|
|
| ICC/IF | (1) |
1/250 - 1/500.
|
| Notes |
|---|
|
WB
1/1000 - 1/10000. Predicted molecular weight: 202 kDa. |
|
ICC/IF
1/250 - 1/500. |
Target
-
Function
Integrin alpha-6/beta-4 is a receptor for laminin. It plays a critical structural role in the hemidesmosome of epithelial cells. -
Tissue specificity
Integrin alpha-6/beta-4 is predominantly expressed by epithelia. Isoform beta-4D is also expressed in colon and placenta. Isoform beta-4E is also expressed in epidermis, lung, duodenum, heart, spleen and stomach. -
Involvement in disease
Defects in ITGB4 are a cause of epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730]; also known as junctional epidermolysis bullosa with pyloric atresia (PA-JEB) or aplasia cutis congenita with gastrointestinal atresia. EB-PA is an autosomal recessive, frequently lethal, epidermolysis bullosa with variable involvement of skin, nails, mucosa, and with variable effects on the digestive system. It is characterized by mucocutaneous fragility, aplasia cutis congenita, and gastrointestinal atresia, which most commonly affects the pylorus. Pyloric atresia is a primary manifestation rather than a scarring process secondary to epidermolysis bullosa.
Defects in ITGB4 are a cause of generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650]. GABEB is a non-lethal, adult form of junctional epidermolysis bullosa characterized by life-long blistering of the skin, associated with hair and tooth abnormalities. -
Sequence similarities
Belongs to the integrin beta chain family.
Contains 1 Calx-beta domain.
Contains 4 fibronectin type-III domains.
Contains 1 PSI domain.
Contains 1 VWFA domain. -
Domain
The fibronectin type-III-like domains bind BPAG1 and plectin and probably also recruit BP230. -
Cellular localization
Membrane. - Information by UniProt
-
Database links
- Entrez Gene: 3691 Human
- Omim: 147557 Human
- SwissProt: P16144 Human
- Unigene: 632226 Human
-
Alternative names
- CD 104 antibody
- CD104 antibody
- CD104 antigen antibody
see all
Images
-
Western blot - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)All lanes : Anti-Integrin beta 4 antibody [EPR8559] (ab133682) at 1/1000 dilution
Lane 1 : BxPC-3 cell lysate
Lane 2 : SW480 cell lysate
Lysates/proteins at 10 µg/ml per lane.
Secondary
All lanes : HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 202 kDa -
![Immunocytochemistry/ Immunofluorescence - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)](https://www.abcam.com/ps/products/133/ab133682/Images/ab133682-226360-anti-integrin-beta-4-antibody-epr8559-immunofluorescence.jpg)
Immunocytochemistry/ Immunofluorescence - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)This image is courtesy of an Abreview submitted by Qingsu Chengab133682 staining Integrin beta 4 in human breast epithelail cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with Triton X-100 and blocked with 1% serum for 1 hour at 25°C. Samples were incubated with primary antibody (1/500 in blocking solution) for 1 hour at 25°C. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG polyclonal (1/100) was used as the secondary antibody.
-
![Immunocytochemistry/ Immunofluorescence - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)](https://www.abcam.com/ps/products/133/ab133682/Images/ab133682-147669-anti-integrin-beta-4-antibody-epr8559-immunofluorescence.jpg)
Immunocytochemistry/ Immunofluorescence - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)Immunofluorescent analysis of BxPC-3 cells labelling Integrin beta 4 with ab133682 at 1/250 dilution. -
![OI-RD Scanning - Anti-Integrin beta 4 antibody [EPR8559] (ab133682)](https://www.abcam.com/ps/products/133/ab133682/Images/ab133682-147668-anti-integrin-beta-4-antibody-epr8559.jpg)
OI-RD Scanning - Anti-Integrin beta 4 antibody [EPR8559] (ab133682) -
![Anti-Integrin beta 4 antibody [EPR8559] (ab133682)](https://www.abcam.com/ps/products/133/ab133682/Images/ab133682-5-benefits-of-recombinant-antibodies.png)
Anti-Integrin beta 4 antibody [EPR8559] (ab133682)
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (6)
ab133682 has been referenced in 6 publications.
- Gao Q et al. Functional Passenger-Strand miRNAs in Exosomes Derived from Human Colon Cancer Cells and Their Heterogeneous Paracrine Effects. Int J Biol Sci 16:1044-1058 (2020). PubMed: 32140072
- Jin SH et al. M. leprae interacts with the human epidermal keratinocytes, neonatal (HEKn) via the binding of laminin-5 with a-dystroglycan, integrin-ß1, or -ß4. PLoS Negl Trop Dis 13:e0007339 (2019). PubMed: 31233498
- Lü Y et al. Berberine regulates the microRNA-21-ITG?4-PDCD4 axis and inhibits colon cancer viability. Oncol Lett 15:5971-5976 (2018). WB . PubMed: 29564000
- Colburn ZT & Jones JCR Complexes of a6ß4 integrin and vimentin act as signaling hubs to regulate epithelial cell migration. J Cell Sci 131:N/A (2018). PubMed: 29976561
- Domke LM & Franke WW The cell-cell junctions of mammalian testes: II. The lamellar smooth muscle monolayer cells of the peritubular wall are laterally connected by vertical adherens junctions-a novel architectonic cell-cell junction system. Cell Tissue Res N/A:N/A (2018). PubMed: 30591979
- Lee JY et al. Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53. J Cancer 8:2124-2131 (2017). PubMed: 28819414